Condition
Biliary Malignant Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Biliary Malignant Tumors clinical trials that are recruiting, in China. By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Personalized mRNA vaccine iNeo-Vac-R01 after surgery for biliary cancer
This trial tests a personalized mRNA vaccine (iNeo-Vac-R01) given after surgery to try to prevent return of biliary malignant tumors in adults.
-
Combining donafenib and capecitabine for treating high-risk biliary cancer after surgery
This study is testing if combining donafenib with capecitabine can help prevent high-risk biliary cancer from coming back after surgery.
Quick answers
How many Biliary Malignant Tumors clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.